NLRP3 and inflammatory bowel disease: NLRP3 inflammasome activation leads to autocrine IL-1β signaling to propagate and amplify the inflammatory response and inflammatory phenotype and increase the persistent IL-1β in intestinal lesions and mucosal cells from IBD patients [58].